Taiwan · Delayed Price · Currency is TWD We Can Medicines Statistics
Total Valuation
TPEX:6929 has a market cap or net worth of TWD 1.44 billion. The enterprise value is 2.35 billion.
| Market Cap | 1.44B |
| Enterprise Value | 2.35B |
Important Dates
The last earnings date was Monday, March 2, 2026.
| Earnings Date | Mar 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6929 has 45.07 million shares outstanding. The number of shares has increased by 3.57% in one year.
| Current Share Class | 45.07M |
| Shares Outstanding | 45.07M |
| Shares Change (YoY) | +3.57% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | n/a |
| Float | 5.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| PB Ratio | 1.37 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | 7.03 |
| P/OCF Ratio | 5.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.38, with an EV/FCF ratio of 11.49.
| EV / Earnings | -32.09 |
| EV / Sales | 0.73 |
| EV / EBITDA | 9.38 |
| EV / EBIT | n/a |
| EV / FCF | 11.49 |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 1.14.
| Current Ratio | 1.53 |
| Quick Ratio | 0.55 |
| Debt / Equity | 1.14 |
| Debt / EBITDA | 4.78 |
| Debt / FCF | 5.86 |
| Interest Coverage | -2.66 |
Financial Efficiency
Return on equity (ROE) is -6.76% and return on invested capital (ROIC) is -3.41%.
| Return on Equity (ROE) | -6.76% |
| Return on Assets (ROA) | -1.40% |
| Return on Invested Capital (ROIC) | -3.41% |
| Return on Capital Employed (ROCE) | -3.35% |
| Weighted Average Cost of Capital (WACC) | 1.53% |
| Revenue Per Employee | 3.21M |
| Profits Per Employee | -72,848 |
| Employee Count | 1,005 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 2.54 |
Taxes
In the past 12 months, TPEX:6929 has paid 18,000 in taxes.
| Income Tax | 18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.82% in the last 52 weeks. The beta is -0.52, so TPEX:6929's price volatility has been lower than the market average.
| Beta (5Y) | -0.52 |
| 52-Week Price Change | -21.82% |
| 50-Day Moving Average | 32.38 |
| 200-Day Moving Average | 32.30 |
| Relative Strength Index (RSI) | 46.39 |
| Average Volume (20 Days) | 8,176 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6929 had revenue of TWD 3.22 billion and -73.21 million in losses. Loss per share was -1.63.
| Revenue | 3.22B |
| Gross Profit | 1.07B |
| Operating Income | -68.02M |
| Pretax Income | -73.19M |
| Net Income | -73.21M |
| EBITDA | -799,000 |
| EBIT | -68.02M |
| Loss Per Share | -1.63 |
Balance Sheet
The company has 285.75 million in cash and 1.20 billion in debt, with a net cash position of -911.59 million or -20.23 per share.
| Cash & Cash Equivalents | 285.75M |
| Total Debt | 1.20B |
| Net Cash | -911.59M |
| Net Cash Per Share | -20.23 |
| Equity (Book Value) | 1.05B |
| Book Value Per Share | 23.26 |
| Working Capital | 501.81M |
Cash Flow
In the last 12 months, operating cash flow was 240.02 million and capital expenditures -35.53 million, giving a free cash flow of 204.50 million.
| Operating Cash Flow | 240.02M |
| Capital Expenditures | -35.53M |
| Depreciation & Amortization | 67.23M |
| Net Borrowing | -242.56M |
| Free Cash Flow | 204.50M |
| FCF Per Share | 4.54 |
Margins
Gross margin is 33.15%, with operating and profit margins of -2.11% and -2.27%.
| Gross Margin | 33.15% |
| Operating Margin | -2.11% |
| Pretax Margin | -2.27% |
| Profit Margin | -2.27% |
| EBITDA Margin | -0.02% |
| EBIT Margin | -2.11% |
| FCF Margin | 6.35% |
Dividends & Yields
TPEX:6929 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.57% |
| Shareholder Yield | -3.57% |
| Earnings Yield | -5.09% |
| FCF Yield | 14.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6929 has an Altman Z-Score of 1.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.65 |
| Piotroski F-Score | 2 |